Biological correlative analyses and updated clinical data of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy: CARTITUDE-2, cohort B.-MedSci.cn

Biological correlative analyses and updated clinical data of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy: CARTITUDE-2, cohort B.

van de Donk, NWCJ; Agha, ME; Cohen, AD; Cohen, YC; Anguille, S; Kerre, T; Roeloffzen, W; Schecter, JM; De Braganca, KC; Varsos, H; Mistry, P; Roccia, T; Zudaire, E; Corsale, C; Akram, M; Geng, D; Nesheiwat, T; Bubuteishvili-Pacaud, L; Sonneveld, P; Zweegman, S

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Biological correlative analyses and updated clinical data of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy: CARTITUDE-2, cohort B.

科室

工具

服务